CompuGroup Medical SE & Co. KGaA
CompuGroup Medical SE: Release of a capital market information
CompuGroup Medical SE / Share Buyback 18.02.2019 / 12:37 Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- CompuGroup Medical SE: Disclosure pursuant to Art. 5 Para. 1 lit. b) and Para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Para. 2 and Para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 - 9th Interim Announcement CompuGroup Medical SE / Share Buyback Koblenz, February 18 2019 CompuGroup Medical SE: Disclosure pursuant to Art. 5 Para. 1 lit. b) and Para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Para. 2 and Para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 - 9th Interim Announcement In the period from February 11, 2019, up to and including February 15, 2019, CompuGroup Medical SE has bought back a total of 46,610 shares of CompuGroup Medical SE within the framework of the share buyback program. In the announcement of December 14, 2018, pursuant to Art. 2 para. 1 of the Commission Delegated Regulation (EU) 2016/1052 supplementing Regulation (EU) No 596/2014 (MAR) it was communicated that the repurchase of treasury shares would commence on December 17, 2018. The overall volume of the shares bought back daily in the period from February 11, 2019, up to and including February 15, 2019, and the daily volume-weighted average stock market prices of the shares are as follows:Date Overall volume of Volume-weighted average shares bought back stock market price (number) (EUR, excluding ancillary costs of purchase, rounded to four places according to commercial practice) February 11, 2019 7,600 49.2279 February 12, 2019 13,250 50.0964 February 13, 2019 6,859 50.4628 February 14, 2019 11,700 51.1470 February 15, 2019 7,201 50.9526 In total: 46,610 50.4047The total number of shares which have been bought back so far by CompuGroup Medical SE since December 17, 2018, up to and including February 15, 2019, within the framework of the share buyback program thus amounts to 270,599 no-par value shares. Further information pursuant to Art. 5 para. 1 lit. b) and para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 para. 2 and para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 is available online under https://www.cgm.com/sbb. The purchase of the shares of CompuGroup Medical SE was carried out by a bank assigned by CompuGroup Medical SE and exclusively via the Frankfurt Stock Exchange (Xetra trading). Koblenz, February 18, 2019 The Management Board CompuGroup Medical SE Investor Relations Maria Trost 21 56070 Koblenz, Germany T: 49 (0) 261 8000-6200 F: 49 (0) 261 8000-3200 --------------------------------------------------------------------------- 18.02.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de --------------------------------------------------------------------------- Language: English Company: CompuGroup Medical SE Maria Trost 21 56070 Koblenz Germany Internet: www.cgm.com End of News DGAP News Service
Aktuelle News
Aktuelle Berichte
Anstehende Events
Events Funktionen
Weitere Funktionen
Webcasts
Keine Webcasts gefunden